Biomet Medical Device Company Intelligence Report

Date: January 22, 2010
Pages: 48
Price:
US$ 515.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B51490121F1EN
Leaflet:

Download PDF Leaflet

Biomet Medical Device Company Intelligence Report
Biomet Inc, an Indiana, US corporation founded in 1977, is one of the largest orthopaedic medical device companies in the US and worldwide with operations in more than 50 locations throughout the world and distribution in approximately 90 countries. The company’s principal subsidiaries include Biomet Orthopedics, Biomet Manufacturing, Biomet Europe, EBI, Biomet 3i, Biomet International, Biomet Microfixation, Biomet Sports Medicine and Biomet Biologics. Biomet and its subsidiaries design and manufacture products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy.

In September 2007, Biomet finalised its merger with LVB Acquisition Merger Sub Inc, a wholly-owned subsidiary of LVB Acquisition Inc, with Biomet being the surviving company of the merger. LVB Acquisition Inc is indirectly-owned by a consortium of private equity funds affiliated with The Blackstone Group, Goldman Sachs, Kohlberg Kravis Roberts and TPG Capital. This consortium, along with other investors, contributed US$5,387.5 million of equity in connection with the transaction. The remaining purchase price of US$6,245.4 million included various proceeds from credit facilities.

Prior to its merger with LVB Acquisition, Biomet had experienced an unsettled 18 months. It lost several of its board members and executives, had been involved in litigation with its shareholders and had to restate its financial results for certain periods following the discovery of stock option programme irregularities. Biomet had also previously been in merger talks with its competitor, Smith & Nephew, but this offer was rejected by Biomet.

In the year ended 31st May 2009, Biomet generated sales of US$2,504 million and employed approximately 7,100 people.
SUMMARY OPERATING RESULTS

OVERVIEW

Recent Key Events

FINANCIAL REVIEW

First Half Fiscal 2010 Financial Results
  Biomet - Quarterly Financial Results, Fiscal Years 2009-2010
  Biomet - Quarterly Sales by Geographic Area, Fiscal Years 2009-2010
  Biomet - Quarterly Revenues by Product Sector, Fiscal Years 2009-2010
  Reconstructive
  Fixation
  Spinal
  Other
Fiscal 2009 Financial Results
  Biomet - Annual Financial Results, Fiscal Years 2005-2009
  Biomet - Annual Revenues and Operating Income/Loss, Fiscal Years 2005-2009
  Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
  Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
  Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
  Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
Biomet - Five Year Financial Data
  Biomet - Five Year Financial Summary, Fiscal Years 2005-2009
Employees
  Biomet Employees

STRATEGIC FOCUS

PRODUCTS

Biomet - FY2009 Revenues by Product Segment
2009 US Musculoskeletal Products Market
Reconstructive Products
2009 US Orthopaedic Reconstructive Products Market
Knee Systems
Hip Systems
Extremity Systems
Dental Reconstructive Devices
Other Reconstructive Products and Services
Fixation Devices
2009 US Fixation Market
Electrical Stimulation Systems
External Fixation Devices
Internal Fixation Devices
Craniomaxillofacial Fixation Systems
Bone Substitute M aterials
Spinal Products
2009 US Spinal Products Market
Spine Fusion Stimulation Systems
Spinal Fixation Systems
Minimally-Invasive Spine Surgery
Vertebral Body Compression Fracture
Bone Substitute and Allograft M aterials
Precision M achined Allograft
Motion Preservation Products
Other Products
Arthroscopy Products
Orthopaedic Support Products
Biomet – 2009 FDA Approvals

RESEARCH AND DEVELOPMENT

Biomet – Annual R&D Expenditure
Clinical Research Support
ONCOR
OREF

MANUFACTURING AND DISTRIBUTION

Biomet’s Principal Manufacturing and Distribution Facilities, May 2009

AGREEMENTS

Agreements Summary
Kensey Nash
Artimplant
Materialise Dental
Collagen M atrix
Marc T ec
aap Implantate
Cytomedix
BrainLAB
ThermoGenesis
Diamicron
CeramTec
Ossacur
Pro-Dex
Z-KAT
Organogenesis
Fermentech
BTG

MERGERS AND ACQUISITIONS

Mergers and Acquisitions Summary
Cartilix
Zhejiang Biomet Medical Products
Interpore Cross International
Merck’s Interest in Biomet Merck
Biolectron
Biogran Dental Grafting Product Line
Implant Innovations International (3i)
Kirschner
Walter Lorenz Surgical Instruments
Electro-Biology
Orthopaedic E quipment Company

LITIGATION

US Department of Justice Consulting Agreement Investigation
US Department of Justice E BI Products Investigations and O ther Matters
US Securities and E xchange Commission Informal Investigation
Massachusetts AG
New Jersey AG
Heraeus Kulzer
Zimmer US
Dr John King

KEY CORPORATE EVENTS

INDEX OF TABLES

SUMMARY OPERATING RESULTS
Recent Key Events
Biomet - Quarterly Financial Results, Fiscal Years 2009-2010
Biomet - Quarterly Sales by Geographic Area, Fiscal Years 2009-2010
Biomet - Quarterly Revenues by Product Sector, Fiscal Years 2009-2010
Biomet - Annual Financial Results, Fiscal Years 2005-2009
Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
Biomet - Five Year Financial Summary, Fiscal Years 2005-2009
Biomet Employees
Biomet – 2009 FDA Approvals
Biomet – Annual R&D Expenditure
Biomet’s Principal Manufacturing and Distribution Facilities, May 2009
Agreements Summary
Mergers and Acquisitions Summary

INDEX OF CHARTS

Biomet - Annual Revenues and Operating Income/Loss, Fiscal Years 2005-2009
Biomet - Annual Sales by Product Sector, Fiscal Years 2005-2009
Biomet - Annual Sales by Geographic Area, Fiscal Years 2005-2009
Biomet - FY2009 Revenues by Product Segment
2009 US Musculoskeletal Products Market
2009 US Orthopaedic Reconstructive Products Market
2009 US Fixation Market
2009 US Spinal Products Market
Skip to top


Ask Your Question

Biomet Medical Device Company Intelligence Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: